10-Hydroxy-2-decenoic acid, a unique medium-chain fatty acid, activates 5'-AMP-activated protein kinase in L6 myotubes and mice

Molecular Nutrition and Food Research

Volumn 57, Issue 10, 2013, Pages 1794-1802

  Takikawa, Masathito ^a   Kumagai, Aya ^a   Hirata, Harumi ^a   Soga, Minoru ^a   Yamashita, Yoko ^b   Ueda, Manabu ^b   Ashida, Hitoshi ^b   Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

10 Hydroxy 2 decenoic acid; 5' AMP activated protein kinase; Ca2+ calmodulin dependent kinase kinase Glucose transporter 4; Royal jelly

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; 10-HYDROXY-2-DECENOIC ACID; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CAMKK1 PROTEIN, RAT; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MONOUNSATURATED FATTY ACID; ROYAL JELLY; SLC2A4 PROTEIN, RAT;

5'-AMP-ACTIVATED PROTEIN KINASE; ANIMAL; ARTICLE; C57BL MOUSE; CA2+/CALMODULIN-DEPENDENT KINASE KINASEΒ/GLUCOSE TRANSPORTER 4; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; RAT; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

10-HYDROXY-2-DECENOIC ACID; 5'-AMP-ACTIVATED PROTEIN KINASE; CA2+/CALMODULIN-DEPENDENT KINASE KINASEΒ/GLUCOSE TRANSPORTER 4; ROYAL JELLY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL LINE; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHOSPHORYLATION; RATS;

EID: 84884942214     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300041     Document Type: Article

References (32)

1. Shepherd, P. R., Kahn, B. B., Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 1999, 341, 248-257.
2. Hawley, S. A., Davison, M., Woods, A., Davies, S. P. et al., Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271, 27879-27887.
3. Hardie, D. G., Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008, 582, 81-89.
4. Kahn, B. B., Alquier, T., Carling, D., Hardie, D. G. et al., AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1, 15-25.
5. Zhou, G., Myers, R., Li, Y., Chen, Y. et al., Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108, 1167-1174.
6. Fryer, L. G., Parbu-Patel, A., Carling, D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277, 25226-25232.
7. Merrill, G. F., Kurth, E. J., Hardie, D. G., Winder, W. W., AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273, 1107-1112.
8. Takikawa, M., Inoue, S., Horio, F., Tsuda, T., Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J. Nutr. 2010, 140, 527-533.
9. Um, J. H., Park, S. J., Kang, H., Yang, S. et al., AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59, 554-563.
10. Pate, N. G., Haydak, M. H., Gochnauer, T. A., Electrophoretic components of the proteins in honeybee larval food. Nature 1960, 186, 633-634.
11. Townsend, G. F., Morgan, J. F., Hazlett, B., Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukemia and ascitic tumors. Nature 1959, 183, 1270-1271.
12. Fujii, A., Kobayashi, S., Kuboyama, N., Furukawa, Y. et al., Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats. Jpn. J. Pharmacol. 1990, 53, 331-337.
13. Münstedt, K., Bargello, M., Hauenschild, A., Royal jelly reduces the serum glucose levels in healthy subjects. J. Med. Food 2009, 12, 1170-1172.
14. Zamami, Y., Takatori, S., Goda, M., Koyama, T. et al., Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol. Pharm. Bull. 2008, 31, 2103-2107.
15. Nomura, M., Maruo, N., Zamami, Y., Takatori, S. et al., Effect of long-term treatment with royal jelly on insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Yakugaku Zasshi 2007, 127, 1877-1882.
16. Lakin, A., Royal jelly and its efficacy. Int. J. Altern. Complement. Med. 1993, 11, 19-22.
17. Takenaka, T., Chemical compositions of royal jelly. Honeybee Sci. 1982, 3, 69-74.
18. Mahadev, K., Wu, X., Zilbering, A., Zhu, L. et al., Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 2001, 276, 48662-48669.
19. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
20. Tsuda, T., Ueno, Y., Aoki, H., Koda, T. et al., Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 2004, 316, 149-157.
21. Nishiumi, S., Ashida, H., Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci. Biotechnol. Biochem. 2007, 71, 2343-2346.
22. Nishiumi, S., Yoshida, M., Azuma, T., Yoshida, K. et al., 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin impairs an insulin signaling pathway through the induction of tumor necrosis factor-alpha in adipocytes. Toxicol. Sci. 2010, 115, 482-491.
23. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L. et al., Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2, 9-19.
24. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005, 280, 29060-29066.
25. Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A. et al., Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 2007, 403, 139-148.
26. Lorente-Cebrián, S., Bustos, M., Marti, A., Martinez, J. A. et al., Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin. Sci. (Lond.) 2009, 117, 243-249.
27. 2+/calmodulin-dependent protein kinase II. Int. J. Biochem. Cell Biol. 2012, 15, 1321-1330.
28. Figueras, M., Olivan, M., Busquets, S., López-Soriano, F. J., Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity 2011, 19, 362-369.
29. Wein, S., Wolffram, S., Schrezenmeir, J., Gasperiková, D. et al., Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. Diabetes Metab. Res. Rev. 2009, 25, 185-194.
30. Schwenk, R. W., Holloway, G. P., Luiken, J. J., Bonen, A. et al., Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82, 149-154.
31. Stahl, A., A current review of fatty acid transport proteins (SLC27). Pflugers Arch. 2004, 447, 722-727.
32. Wiczer, B. M., Lobo, S., Machen, G. L., Graves, L. M. et al., FATP1 mediates fatty acid-induced activation of AMPK in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2009, 387, 234-238.